Director/PDMR Shareholding

November 26, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 23 November 2018 it purchased 1,000,000 Ordinary Shares of 1p in the capital of the Company ("Ordinary Shares") at 3.16p per Ordinary Share (the “Purchase”). Following the purchase, Vulpes has a total direct and indirect interest in 64,946,734 equivalent to 22% of Proteome Sciences' total issued share capital.

Back to News